Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Equillium (EQ) Revenue (2022 - 2024)

Equillium (EQ) has disclosed Revenue for 3 consecutive years, with $4.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Revenue fell 52.32% to $4.4 million in Q4 2024 year-over-year; TTM through Sep 2025 was $4.4 million, a 90.43% decrease, with the full-year FY2024 number at $41.1 million, up 13.89% from a year prior.
  • Revenue was $4.4 million for Q4 2024 at Equillium, down from $12.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $13.9 million in Q2 2024 to a low of -$271000.0 in Q4 2022.
  • A 3-year average of $6.3 million and a median of $8.9 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 3622.78% in 2023, then plummeted 52.32% in 2024.
  • Equillium's Revenue stood at -$271000.0 in 2022, then surged by 3498.89% to $9.2 million in 2023, then tumbled by 52.32% to $4.4 million in 2024.
  • Per Business Quant, the three most recent readings for EQ's Revenue are $4.4 million (Q4 2024), $12.2 million (Q3 2024), and $13.9 million (Q2 2024).